Whitener Capital Management, Inc. Alkermes Plc. Transaction History

Whitener Capital Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 02, 2019	SELL	$28.4 - $36.49 $1,420 - $1,824	-50 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$38.6 - $46.12 $1,930 - $2,306	50 New	50 $2,000
Q2 2018 Aug 08, 2018	SELL	$40.56 - $51.36 $2,028 - $2,568	-50 Closed	0 $0
Q4 2017 Apr 23, 2018	BUY	$47.69 - $55.39 $2,384 - $2,769	50	50 $2,000

349

183M

209K

89.4K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.34B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Whitener Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Whitener Capital Management, Inc. with notifications on news.